» Articles » PMID: 19056102

The Large Form of Human 2',5'-Oligoadenylate Synthetase (OAS3) Exerts Antiviral Effect Against Chikungunya Virus

Overview
Journal Virology
Specialty Microbiology
Date 2008 Dec 6
PMID 19056102
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Chikungunya virus (CHIKV) becomes one of the most important mosquito-borne alphavirus in the medical field. CHIKV is highly sensitive to antiviral activity of Type-I interferons (IFN-alpha/beta). Here, we investigated the role of IFN-induced 2',5'-Oligoadenylate Synthetase (OAS) family in innate immunity to CHIKV. We established inducible human epithelial HeLa cell lines expressing either the large form of human OAS, OAS3, or the genetic variant OAS3-R844X which is predicted to lack about 20% of the OAS3 protein from the carboxy terminus. HeLa cells respond to ectopic OAS3 expression by efficiently inhibiting CHIKV growth. The characteristic of the antiviral effect was a blockade in early stages of virus replication. Thus, OAS3 pathway may represent a novel antialphaviral mechanism by which IFN-alpha/beta controls CHIKV growth. HeLa cells expressing the truncated form of OAS3 were less resistant to CHIKV infection, raising the question on the involvement of OAS3 genetic polymorphism in human susceptibility to alphavirus infection.

Citing Articles

Interaction of chikungunya virus glycoproteins with macrophage factors controls virion production.

Yao Z, Ramachandran S, Huang S, Kim E, Jami-Alahmadi Y, Kaushal P EMBO J. 2024; 43(20):4625-4655.

PMID: 39261662 PMC: 11480453. DOI: 10.1038/s44318-024-00193-3.


Unraveling the complex interplay: immunopathology and immune evasion strategies of alphaviruses with emphasis on neurological implications.

de Oliveira Souza R, Duarte Junior J, Della Casa V, Santoro Rosa D, Renia L, Claser C Front Cell Infect Microbiol. 2024; 14:1421571.

PMID: 39211797 PMC: 11358129. DOI: 10.3389/fcimb.2024.1421571.


Live-attenuated CHIKV vaccine with rearranged genome replicates in vitro and induces immune response in mice.

Tretyakova I, Joh J, Gearon M, Kraenzle J, Goedeker S, Pignataro A PLoS Negl Trop Dis. 2024; 18(4):e0012120.

PMID: 38648230 PMC: 11075892. DOI: 10.1371/journal.pntd.0012120.


UiO-66 nanoparticles combat influenza A virus in mice by activating the RIG-I-like receptor signaling pathway.

Su R, Li X, Xiao J, Xu J, Tian J, Liu T J Nanobiotechnology. 2024; 22(1):99.

PMID: 38461229 PMC: 10925002. DOI: 10.1186/s12951-024-02358-y.


The Many Faces of Oligoadenylate Synthetases.

Sarkar S, Harioudh M, Shao L, Perez J, Ghosh A J Interferon Cytokine Res. 2023; 43(11):487-494.

PMID: 37751211 PMC: 10654648. DOI: 10.1089/jir.2023.0098.